STOCK TITAN

[Form 4] Definitive Healthcare Corp. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Definitive Healthcare Corp. (DH) insider Jason R. Krantz reported a transaction on 09/14/2025. The filing shows a disposition of 4,093 shares of Class A common stock at $4.15 per share, recorded as a sale to satisfy tax withholding related to vested restricted stock units. After the transaction, Mr. Krantz directly beneficially owns 1,079,380 shares and indirectly owns 450,000 shares held in trust by DH Holdings (formerly the Jason R. Krantz 2009 Trust). The filing was signed by an attorney-in-fact on 09/16/2025.

Definitive Healthcare Corp. (DH) insider Jason R. Krantz ha riportato una transazione il 14/09/2025. La pratica mostra una cessione di 4.093 azioni di Class A a 4,15 dollari ciascuna, registrata come vendita per soddisfare la ritenuta fiscale legata alle RSU maturate. Dopo la transazione, il signor Krantz detiene direttamente 1.079.380 azioni e indirettamente 450.000 azioni detenute in trust da DH Holdings (ex Jason R. Krantz 2009 Trust). La pratica è stata firmata da un procuratore in atto il 16/09/2025.

El directivo de Definitive Healthcare Corp. (DH), Jason R. Krantz, informó de una transacción el 14/09/2025. La presentación muestra la disposición de 4.093 acciones de Class A a 4,15 dólares por acción, registrada como venta para satisfacer la retención de impuestos relacionada con las RSU vestidas (restricted stock units). Después de la transacción, el señor Krantz posee directamente 1.079.380 acciones y posee indirectamente 450.000 acciones en fideicomiso de DH Holdings (anteriormente el Jason R. Krantz 2009 Trust). La presentación fue firmada por un apoderado el 16/09/2025.

Definitive Healthcare Corp. (DH) 내부자 Jason R. Krantz가 2025년 9월 14일 거래를 보고했습니다. 제출서는 RSU가 취득되면서 필요한 세금 원천징수를 충족하기 위해 4,093주당 4.15달러로 Class A 보통주의 처분을 나타냅니다. 거래 이후 Krantz 씨는 직접적으로 1,079,380주를, 간접적으로 DH Holdings(구 Jason R. Krantz 2009 Trust)가 보유한 신탁의 450,000주를 보유합니다. 제출서는 2025년 9월 16일 대리인이 서명했습니다.

Un initié de Definitive Healthcare Corp. (DH), Jason R. Krantz, a signalé une transaction le 14/09/2025. Le dépôt indique une cession de 4 093 actions ordinaires de classe A à 4,15 $ par action, enregistrée comme vente pour satisfaire à la retenue d'impôt liée aux RSU acquises. Après la transaction, M. Krantz détient directement 1 079 380 actions et indirectement 450 000 actions détenues en fiducie par DH Holdings (anciennement le Jason R. Krantz 2009 Trust). Le dépôt a été signé par un mandataire le 16/09/2025.

Insider von Definitive Healthcare Corp. (DH), Jason R. Krantz, meldete eine Transaktion am 14.09.2025. Die Einreichung zeigt eine Veräußerung von 4.093 Class A Stammaktien zum Preis von 4,15 USD pro Aktie an, registriert als Verkauf zur Deckung der Steuerabführung im Zusammenhang mit vesteten RSUs (Restricted Stock Units). Nach der Transaktion besitzt Herr Krantz direkt 1.079.380 Aktien und besitzt indirekt 450.000 Aktien, die von DH Holdings (früher der Jason R. Krantz 2009 Trust) treuhänderisch gehalten werden. Die Einreichung wurde von einem Bevollmächtigten am 16.09.2025 unterzeichnet.

أبلغ شخص مطّلع في شركة Definitive Healthcare Corp. (DH) وهو Jason R. Krantz عن صفقة في 14/09/2025. يظهر هذا الإيداع بيعاً لــ 4,093 سهماً من الفئة A بسعر 4.15 دولار للسهم، وم recorded كبيع لتلبية الاحتجاز الضريبي المرتبط بوحدات الأسهم المقيدة المكتسبة (RSU). بعد الصفقة، يمتلك السيد Krantz بشكل مباشر 1,079,380 سهماً وبشكل غير مباشر 450,000 سهم محتوَاة في صندوق ائتماني من قبل DH Holdings (المسمّى سابقاً Jason R. Krantz 2009 Trust). كما تم توقيع الإيداع من قبل وكيل قانوني في 16/09/2025.

Definitive Healthcare Corp. (DH) 的内部人士 Jason R. Krantz 于 2025-09-14 报告了一笔交易。 文件显示以每股 4.15 美元的价格处置了 4,093 股 A 类普通股,记录为为满足已归属的受限股票单位(RSU)所需的税务代扣而进行的出售。交易后,Krantz 先生直接持有 1,079,380 股,间接持有 450,000 股,由 DH Holdings(前 Jason R. Krantz 2009 Trust)信托持有。该文件由授权代理人在 2025-09-16 签署。

Positive
  • Retains large stake: Direct ownership of 1,079,380 shares plus 450,000 shares indirectly held preserves significant alignment with shareholders.
  • Clear disclosure: Footnotes explain the sale was for tax withholding on vested RSUs, providing transparency about the transaction's purpose.
Negative
  • Minor dilution of personal holdings: A disposition of 4,093 shares reduced direct holdings, though amount is small relative to total ownership.

Insights

TL;DR: Routine tax-withholding sale; large remaining ownership retains alignment with shareholders.

The reported disposition of 4,093 shares at $4.15 appears to be a standard withholding event tied to RSU vesting rather than an open-market sale for liquidity. The reporting person still directly holds 1,079,380 shares and indirectly holds 450,000 shares in trust, representing a substantial ownership stake that preserves alignment with company performance. No derivative transactions or additional dispositions are reported. Impact on float and immediate market supply is minimal given the small size of the sale relative to total holdings.

TL;DR: Disclosure consistent with Section 16 requirements; nature of indirect holdings is documented.

The form properly discloses relationship (Director and 10% owner) and specifies that 450,000 shares are held in trust by DH Holdings (f/k/a Jason R. Krantz 2009 Trust), with the reporting person as beneficiary. The explanatory footnotes clarify the tax-withholding nature of the transaction. Filing completeness and signature by attorney-in-fact meet procedural norms. No governance red flags or unexplained related-party transfers are evident from the form alone.

Definitive Healthcare Corp. (DH) insider Jason R. Krantz ha riportato una transazione il 14/09/2025. La pratica mostra una cessione di 4.093 azioni di Class A a 4,15 dollari ciascuna, registrata come vendita per soddisfare la ritenuta fiscale legata alle RSU maturate. Dopo la transazione, il signor Krantz detiene direttamente 1.079.380 azioni e indirettamente 450.000 azioni detenute in trust da DH Holdings (ex Jason R. Krantz 2009 Trust). La pratica è stata firmata da un procuratore in atto il 16/09/2025.

El directivo de Definitive Healthcare Corp. (DH), Jason R. Krantz, informó de una transacción el 14/09/2025. La presentación muestra la disposición de 4.093 acciones de Class A a 4,15 dólares por acción, registrada como venta para satisfacer la retención de impuestos relacionada con las RSU vestidas (restricted stock units). Después de la transacción, el señor Krantz posee directamente 1.079.380 acciones y posee indirectamente 450.000 acciones en fideicomiso de DH Holdings (anteriormente el Jason R. Krantz 2009 Trust). La presentación fue firmada por un apoderado el 16/09/2025.

Definitive Healthcare Corp. (DH) 내부자 Jason R. Krantz가 2025년 9월 14일 거래를 보고했습니다. 제출서는 RSU가 취득되면서 필요한 세금 원천징수를 충족하기 위해 4,093주당 4.15달러로 Class A 보통주의 처분을 나타냅니다. 거래 이후 Krantz 씨는 직접적으로 1,079,380주를, 간접적으로 DH Holdings(구 Jason R. Krantz 2009 Trust)가 보유한 신탁의 450,000주를 보유합니다. 제출서는 2025년 9월 16일 대리인이 서명했습니다.

Un initié de Definitive Healthcare Corp. (DH), Jason R. Krantz, a signalé une transaction le 14/09/2025. Le dépôt indique une cession de 4 093 actions ordinaires de classe A à 4,15 $ par action, enregistrée comme vente pour satisfaire à la retenue d'impôt liée aux RSU acquises. Après la transaction, M. Krantz détient directement 1 079 380 actions et indirectement 450 000 actions détenues en fiducie par DH Holdings (anciennement le Jason R. Krantz 2009 Trust). Le dépôt a été signé par un mandataire le 16/09/2025.

Insider von Definitive Healthcare Corp. (DH), Jason R. Krantz, meldete eine Transaktion am 14.09.2025. Die Einreichung zeigt eine Veräußerung von 4.093 Class A Stammaktien zum Preis von 4,15 USD pro Aktie an, registriert als Verkauf zur Deckung der Steuerabführung im Zusammenhang mit vesteten RSUs (Restricted Stock Units). Nach der Transaktion besitzt Herr Krantz direkt 1.079.380 Aktien und besitzt indirekt 450.000 Aktien, die von DH Holdings (früher der Jason R. Krantz 2009 Trust) treuhänderisch gehalten werden. Die Einreichung wurde von einem Bevollmächtigten am 16.09.2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Krantz Jason Ronald

(Last) (First) (Middle)
C/O DEFINITIVE HEALTHCARE CORP.
492 OLD CONNECTICUT PATH, SUITE 401

(Street)
FRAMINGHAM MA 01701

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Definitive Healthcare Corp. [ DH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) X Other (specify below)
EXECUTIVE CHAIRMAN
3. Date of Earliest Transaction (Month/Day/Year)
09/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 09/14/2025 F(1) 4,093 D $4.15 1,079,380 D
Class A Common Stock 450,000 I See footnote(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units.
2. Amount beneficially owned in trust by DH Holdings (f/k/a Jason R. Krantz 2009 Trust), of which the reporting person is the beneficiary.
/s/ Maria Borda, Attorney-in-Fact 09/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Jason R. Krantz report on Form 4 for Definitive Healthcare (DH)?

The filing reports a disposition of 4,093 shares of Class A common stock on 09/14/2025 at a reported price of $4.15 per share.

Why were the shares disposed according to the Form 4?

Footnote 1 states the shares were withheld by the issuer to satisfy the reporting person’s tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units.

How many shares does Jason R. Krantz beneficially own after the transaction?

After the reported transaction, he directly beneficially owns 1,079,380 shares and indirectly beneficially owns 450,000 shares held in trust.

What is the nature of the indirect holdings reported on the Form 4?

Footnote 2 clarifies the 450,000 shares are beneficially owned in trust by DH Holdings (formerly the Jason R. Krantz 2009 Trust), of which the reporting person is the beneficiary.

When was the Form 4 signed and filed?

The filing shows the signature by attorney-in-fact Maria Borda on 09/16/2025.
Definitive Healthcare Corp.

NASDAQ:DH

DH Rankings

DH Latest News

DH Latest SEC Filings

DH Stock Data

400.73M
29.66M
9.42%
95.91%
4%
Health Information Services
Services-prepackaged Software
Link
United States
FRAMINGHAM